Prince Pharma Pharmaceutical Import Profile — Congo Dr (DGFT 2022–2026)

Name: Prince Pharma Pharmaceutical Import Records from India — 2 Products, $163.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Prince Pharma — Pharmaceutical Importer Profile (2026) | 2 Products, $163.7K Trade | TransData Nexus

Prince Pharma

Pharmaceutical Importer · Congo Dr · Advanced Antibiotics Focus · $163.7K Total Trade · DGFT Verified

Prince Pharma is a pharmaceutical importer based in Congo Dr with a total trade value of $163.7K across 2 products in 2 therapeutic categories. Based on 39 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Prince Pharma sources from 61 verified Indian suppliers, with Prashi Pharma Private Limited accounting for 40.0% of imports.

Prince Pharma — Import Portfolio & Supplier Network

Prince Pharma import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Prince Pharma?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Prashi Pharma Private Limited	$16.4M	1,417	40.0%
Vidacare Medica Private Limited	$3.3M	281	8.0%
Syncom Formulations (india) Limited	$3.2M

What Formulations Does Prince Pharma Import?

Formulation	Value	Ships
Tetracycline capsule BP 250 MG Each CAPS	$564.0K	19
Cypro-500 tablets Each film coated	$538.0K	22
Metro - 250 tablets Each film coated	$514.7K	25
Volpa tablets Each uncoated tablets	$398.1K	26
Ibutec forte capsules Each capsules	$331.5K	12
Griseofulvin tablets b.p. 500 MG Each	$316.4K	10
Tetracycline capsule BP 250 MG Each capsule contains: tetracycline hcl BP 250 MG	$314.4K	18
Artemether/lumefantrine 20MG/120MG	$283.0K	12
Paracetamol tablets b p 500 MG Each uncoated tablets contains paracetamol b p 500 MG	$267.4K	7
Diclofenac tablets 50MG Each film coated tablets contains : diclofenac sodiumb.p. 50 MG	$253.4K	12
Ibutec capsules Each capsules	$252.8K	10
Tetracycline casule BP 250 MG Each	$250.9K	9
Lincomycin capsule BP 500MG Each	$243.2K	9
Metro - 250 tablets Each film coated tablets contains :metronidazole b.p. 250 MG	$237.6K	14
Metro - 250 tablets Each film coated tablets contains : metronidazole b.p. 250 MG	$223.8K	15

Prince Pharma imports 2,286 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Norfloxacin	Advanced Antibiotics	$88.8K	20	1.1%	12
2	Diazepam	CNS & Psychiatric	$74.9K	19	1.0%	15

Prince Pharma imports 2 pharmaceutical products across 2 categories into Congo Dr totaling $163.7K.

Prince Pharma — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Prince Pharma is a leading pharmaceutical company based in Kinshasa, the capital of the Democratic Republic of Congo (DRC). Established over 15 years ago, the company specializes in importing and distributing a wide range of generic and branded medicines across various therapeutic areas. Their product portfolio includes both prescription and over-the-counter medications, catering to diverse healthcare needs within the DRC. (princepharma.co)

The company's medicines are manufactured in WHO-approved facilities in India and China, ensuring high efficacy and affordability. Prince Pharma's extensive distribution network ensures that their products are accessible throughout the country, including remote areas. Their commitment to continuous medical education for healthcare providers and addressing unmet healthcare needs underscores their role in enhancing the quality of healthcare in the DRC. (princepharma.co)

2Distribution Network

Prince Pharma operates a modern, ISO 9001:2015-certified warehouse equipped with Warehouse Management System (WMS) software and an automated system that streamlines picking and optimizes inventory. This facility forecasts demand and maintains controlled temperatures for perishable goods through real-time temperature monitoring. Their distribution network comprises numerous outlets and warehouses, ensuring effortless product availability throughout the DRC for optimal service. (princepharma.co)

3Industry Role

In the DRC's pharmaceutical supply chain, Prince Pharma functions primarily as a pharmaceutical importer and distributor. By sourcing medicines from international manufacturers and ensuring their availability across the country, they play a crucial role in meeting the healthcare needs of the Congolese population. Their extensive distribution network and commitment to quality make them a significant player in the DRC's pharmaceutical sector. (princepharma.co)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Prince Pharma

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Prince Pharma's sourcing strategy reveals a high concentration of imports from a select group of Indian suppliers. The top five suppliers account for 100% of their imports, with PRASHI PHARMA PRIVATE LIMITED leading at 40% of the total import value. This indicates a strategic choice to maintain strong, stable relationships with key suppliers, ensuring consistent product quality and supply. However, such concentration also poses risks; any disruption with these suppliers could significantly impact Prince Pharma's operations. The shipment data suggests a stable relationship, as evidenced by the consistent number of shipments over the years. Nonetheless, diversifying the supplier base could mitigate potential risks associated with over-reliance on a few suppliers.

2Supply Chain Resilience

Prince Pharma's supply chain resilience is bolstered by its partnerships with reputable Indian pharmaceutical manufacturers, all of which are WHO-approved. This ensures adherence to international quality standards. The company's modern warehousing facilities, equipped with automated systems and real-time monitoring, further enhance supply chain efficiency. However, the heavy reliance on a limited number of suppliers may expose the company to risks if any of these suppliers face operational challenges. To strengthen resilience, establishing relationships with additional suppliers and diversifying the product portfolio could be beneficial.

Importing Pharmaceuticals into Congo Dr — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Congo Dr

1Regulatory Authority & Framework

The Congolese Pharmaceutical Regulatory Authority (ACOREP) is responsible for regulating pharmaceutical imports and exports in the DRC. ACOREP oversees the authorization and control of drug imports, ensuring compliance with national and international standards. The regulatory framework includes obtaining an import license from an authorized commercial bank and undergoing a pre-shipment inspection by Bureau Veritas for shipments valued over $2,500.

2Import Licensing & GMP

Importers in the DRC must secure an import license from an authorized commercial bank before the physical shipment of goods. A pre-shipment inspection is mandatory for all imports valued at $2,500 FOB or greater. While Good Manufacturing Practice (GMP) certification is officially required, enforcement is often inconsistent; a Certificate of Pharmaceutical Product (CPP) is a critical document.

3Quality & Labeling

Imported pharmaceutical products must undergo quality control processes, including initial screening conducted locally using methods like the GPHF Minilab, with more comprehensive analysis performed at WHO-prequalified laboratories abroad. All documentation and labeling must be in French, as it is the official language of the DRC. Non-compliance with these requirements can lead to significant sanctions, including product recalls and fines.

Prince Pharma — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Prince Pharma's focus on importing advanced antibiotics and CNS & psychiatric medications aligns with the significant healthcare needs in the DRC. The high import values of Norfloxacin and Diazepam indicate substantial market demand for these therapeutic areas. This strategic focus enables Prince Pharma to address critical health challenges and position itself as a key supplier in these segments.

2Sourcing Profile

Prince Pharma's sourcing strategy emphasizes importing finished pharmaceutical formulations from WHO-approved manufacturers in India and China. This approach ensures adherence to international quality standards and meets the therapeutic needs of the DRC market. The company's reliance on a select group of suppliers reflects a strategic choice to maintain strong, stable relationships, although it also presents potential risks associated with supplier concentration.

3Market Positioning

Based on its product mix, Prince Pharma serves a broad segment of the DRC market, including retail pharmacies, hospitals, and government tenders. The company's extensive distribution network and focus on essential therapeutic areas position it as a key player in the Congolese pharmaceutical sector, catering to diverse healthcare needs across the country.

Seller's Guide — How to Become a Supplier to Prince Pharma

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the DRC market by meeting Prince Pharma's quality standards and supply requirements. Diversifying the supplier base could mitigate potential risks associated with over-reliance on a few suppliers. Additionally, expanding the product portfolio to include other therapeutic areas could address unmet healthcare needs in the DRC, presenting growth opportunities for both Prince Pharma and potential suppliers.

2Requirements & Qualifications

Indian exporters seeking to supply Prince Pharma and the DRC market must ensure their products meet international quality standards and obtain necessary certifications, such as GMP and CPP. Compliance with DRC import regulations, including obtaining an import license and undergoing pre-shipment inspections, is mandatory. All documentation and labeling must be in French to meet regulatory requirements.

3How to Approach

To establish a relationship with Prince Pharma, Indian exporters should ensure their products meet the required quality standards and certifications. Engaging in direct communication to understand Prince Pharma's specific needs and participating in tenders can facilitate entry into the DRC market. Understanding and complying with the DRC's import regulations, including obtaining the necessary import licenses and ensuring all documentation is in French, is crucial. Building a strong, reliable partnership with Prince Pharma can lead to sustained success in the Congolese pharmaceutical market.

Frequently Asked Questions — Prince Pharma

What products does Prince Pharma import from India?

Prince Pharma imports 2 pharmaceutical products across 2 categories. Top imports: Norfloxacin ($88.8K), Diazepam ($74.9K).

Who supplies pharmaceuticals to Prince Pharma from India?

Prince Pharma sources from 61 verified Indian suppliers. The primary supplier is Prashi Pharma Private Limited (40.0% of imports, $16.4M).

What is Prince Pharma's total pharmaceutical import value?

Prince Pharma's total pharmaceutical import value from India is $163.7K, based on 39 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Prince Pharma focus on?

Prince Pharma imports across 2 categories. The largest: Advanced Antibiotics (54.3%), CNS & Psychiatric (45.7%).

Get Full Prince Pharma Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.